Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.

Chagas' disease is caused by unicellular parasite Trypanosoma cruzi (T. cruzi). It is endemic throughout Latin America, but nowadays has become a global challenge due to tourism and migration. Non-treated infection may result in health-threatening complications and lead to death. Current medications for this infection are nifurtimox (NFT) and benznidazol. Both drugs may cause side effects and are ineffective in the chronic phase. Therefore, new antichagasic compounds are urgently required. Nitazoxanide (NTZ) is a broad spectrum antiparasitic drug, proposed recently as a potential candidate to be added to the list of essential medicines for integrated neglected tropical disease control and elimination. Although the effect of NTZ against T. cruzi epimastigotes in vitro was reported, the corresponding experiments in animal models of T. cruzi infection have never been undertaken. The present work was designed to fill this gap and evaluate the effect of NTZ on experimental murine trypanosomiasis, in comparison with classical antichagasic agent NFT. Highly sensitive to T. cruzi BALB/c mice were infected using Albarrada T. cruzi strain, recently isolated in Mexico. Experimental groups were either left untreated, or otherwise treated with NFT, NTZ (100 and 1000 mg/kg), or with both drugs simultaneously. The severity of the infection was estimated based on criteria such as parasitemia, lesions in target tissues (heart, muscles and lungs) and mortality. Despite the expected protective effect, NTZ drastically aggravates the course of T. cruzi infection. Namely, parasitemia, tissue lesions and mortality caused by T. cruzi infection were significantly higher in NTZ-treated mice groups, even in comparison with untreated infected animals. NTZ by itself no produced mortality o tissue damage, and NFT showed an expected protective effect. Our results indicate that NTZ cannot be considered for Chagas' disease treatment. Moreover, NTZ should be used with caution in patients positive for T. cruzi infection.

Synthesis and Characterization of Hollow Mesoporous Silica Nanoparticles for Smart Corrosion Protection.

Different approaches have been considered for the development of smart anticorrosive coatings by the incorporation of nanocontainers loaded with corrosion inhibitors into the protective layer. Nanocontainers are designed to allow a controlled release of the inhibitor in response to an external stimulus, thus, achieving more efficient and more economical use of the active component. In this case, a pH change is a very interesting stimulus to trigger the release because corrosion processes cause local pH changes. To this end, a special focus has been placed on the use of mesoporous silica nanoparticles (MSN) as nanocontainers due to their interesting characteristics, such as larger surface area, versatile functionalisation, stability, etc. However, the use of hollow mesoporous silica nanoparticles (HMSN), with a large central hole combined with an external mesoporous silica shell, offers an additional advantage due to the higher loading capacity. In the present work, HMSN have been efficiently synthesised, loaded with sodium phosphomolybdate, as a non-toxic alternative to the use of chromates, and encapsulated by a layer of an oppositely charged polyelectrolyte, poly(diallyldimethylammonium chloride) (PDDA). The morphology and textural properties of the produced nanocapsules have been studied by different techniques (SEM/EDS, TEM/EDS, Brunauer⁻Emmett⁻Teller (BET) analysis method, ζ-potential). Finally, the releasing capacity and corrosion protection at different pH values have been studied, confirming the smart behaviour of the encapsulated loaded HMSN.